Nested Case-control Analysis of the Influence of the Microbiome on Rotavirus Vaccine Immunogenic Response in Infants in Karachi, Pakistan
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 88
- 试验地点
- 1
- 主要终点
- differences in fecal microbiota composition
研究概览
简要总结
This is a nested case-control study within an ongoing rotavirus vaccine immunogenicity trial in Karachi, Pakistan. The primary study aim is to compare the fecal microbiota composition and diversity of infants who do (control) and do not (case) demonstrate immune seroconversion to rotavirus vaccination. The infants will be matched for vaccination dose, age and breast-feeding practices.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 6 Weeks 至 3 Years（Child）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Infants already consented and enrolled in the overarching study: Immunogenicity of Rotavirus Vaccine Under Different Age Schedules and the Impact of Withholding Breast Feeding around the Time of Vaccination on the Immunogenicity or Rotarix Vaccine trial (NCT01199874)
- •Overarching study (NCT01199874)inclusion criteria:
- •6 weeks 0 days to 7 weeks 6 days age at the time of enrollment
- •Healthy infant free of chronic or serious medical condition as determined by history and physical exam at time of enrollment
- •written informed consent obtained from parents or guardians for overarching study Nested study additional inclusion criteria
- •written informed consent obtained from parents or legal guardians for this nested study
- •availability of a baseline, pre-vaccination fecal sample
排除标准
- •Overarching study (NCT01199874)exclusion criteria
- •hypersensitivity to any of the vaccine components
- •Use of any investigational drug or vaccine other than the study vaccine within 30 days of first dose of study vaccine or during the study
- •use of any immunosuppressive drugs
- •previous intussusceptions or abdominal surgery
- •enrollment in any other trials
- •birth weight less than 1500 grams; or if birthweight is unknown, weight less than 2000 grams on or before 28 days
- •immunoglobulin and/or blood products use since birth or during the study period Nested study additional exclusion criteria
- •positive serum anti-rotavirus IgA (> or= 20U/mL) at 6 weeks of age, indicative of rotavirus infection prior to vaccination
结局指标
主要结局
differences in fecal microbiota composition
时间窗: 2 years
The primary study objective is to see if there are significant differences in the fecal microbiota composition between rotavirus vaccine (Rotarix TM) immune responders (defined as anti-RV IgA antibodies at a concentration of \> or = to 20 U/ml in a previously seronegative individual 4 weeks after the last Rotarix dose) and rotavirus vaccine immune non-responders (defined as anti-RV IgA antibodies at a concentration of \<20 U/mL 4 weeks after the last Rotarix dose)
次要结局
未报告次要终点
研究者
Vanessa Harris
Principal Investigator
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)